About Us

As a pharmaceutical company headquartered in Zurich, Switzerland, we develop, manufacture and internationally market well-proven and innovative pharmaceuticals in novel drug delivery forms.

Established in 1836, today Acino has a global footprint with the clear focus on over 90 high-growth markets. Our company has evolved significantly in the past decades, and we happily celebrate our cultural and geographic diversity.​

As a leader in advanced drug delivery technologies with a focus on modified release and dispersible forms, for which we also hold patents, we are renowned for the quality of products, people, and service.

  • >€653m

    Group sales
    for full-year 2023

  • >88%

    Sales % in high-growth markets
    in 2023

  • 3,087

    as of end of 2023

We Are Acino

We have a bold ambition

  • To stand out in the world of pharma
  • To be proudly different
  • To have a human face, not a corporate face

Global footprint

  • 6

    Manufacturing sites:
    Switzerland (2), Ukraine,
    Estonia, United Arab Emirates
    and South Africa

  • 5

    Regional offices:
    Dubai, Kyiv, Johannesburg,
    Mexico City and Panama City

Join Us

Interested in a challenging, rewarding role with Acino? Visit our Career page.

Open for Partnerships

We believe in entering partnerships for the expansion of our product portfolio, the acquisition of unique drug delivery technologies, and for specific dossiers that meet our commercial plans. We provide contract manufacturing services, offer products through distribution deals, as well as through out- and in-licensing. We strive for long-lasting relationships with suppliers, distributors, and customers.